-
High Demand for Radiation-Free Ultrasound to Dominate Ophthalmic Ultrasound System Market’s Future
Sep 30, 2016, 04:19 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 30, 2016 - Ultrasound systems have become as indispensable in the field of ophthalmology as standard clinical assessment modalities such as slit lamp or indirect ophthalmoscopy, the standard means for evaluating the anterior segment of the retinaFull story -
Quertle releases Qinsight — a biomedical literature discovery product built on its BioAI artificial intelligence platform
Sep 29, 2016, 18:35 PM by Michael CroftHENDERSON, NV, UNITED STATES - Sep 29, 2016 - Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI), has released QinsightFull story -
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Sep 29, 2016, 16:35 PM by Michael CroftFull storyBio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Sep 29, 2016, 13:45 PM by Michael CroftBio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.Full story -
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Sep 29, 2016, 11:05 AM by Michael CroftBio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.Full story -
SANECA PHARMA INVESTS IN SMALL SCALE API CAPABILITIES
Sep 29, 2016, 10:26 AM by Michael CroftHLOHOVEC, SLOVAKIA - Sep 29, 2016 - CONTRACT development and manufacturing organisation (CDMO) Saneca Pharma is investing heavily in its API capabilities to support client demand for smaller batch sizes and streamlined scale-upFull story -
Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval
Sep 29, 2016, 09:45 AM by Michael CroftMIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.Full story -
Pharmaceutical and Biotechnology Companies are Catering the Needs of Visual Disorders
Sep 29, 2016, 08:31 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 29, 2016 - Although there are significant progress in preventing and curing visual impairment in many countries since last twenty years, according to World Health Organization (WHO) around 285 million (In the year 2013) people are still visually impaired across the worldFull story -
Worldwide Increasing Elderly Population Drives Industry of Rehabilitation Robots
Sep 29, 2016, 08:07 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 29, 2016 - The robotic rehabilitation and assistive technologies market accounts for rehabilitation robots and assistive technology robotsFull story -
PRP: Work and Accidents - Stop Working & Living With Pain
Sep 28, 2016, 15:35 PM by Michael CroftWESTMINSTER, UNITED STATES - Sep 29, 2016 - PRP is used to return injured back to the work / life quicker. PRP speeds-up the healing process and get patient back to their usual healthy conditionFull story -
Sarapin for Chronic Pain Relief
Sep 28, 2016, 14:36 PM by Michael CroftSALT LAKE CITY, UT, UNITED STATES - Sep 29, 2016 - Odds are you probably havent. However, if you have ever suffered for chronic back, neck, or joint pain the odds are overwhelming that you have probably heard of cortisoneFull story -
Why Big Pharma Wants To Collect 2 Million Genomes
Sep 28, 2016, 12:26 PM by Michael CroftNature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.Full story -
Microsoft Goes All in for FPGAs to Build Out AI Cloud
Sep 28, 2016, 11:26 AM by Michael CroftTOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."Full story -
Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target
Sep 28, 2016, 11:25 AM by Michael CroftFull storyBio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.
-
ZENITH TECHNOLOGIES APPOINTS MES LEAD
Sep 28, 2016, 06:40 AM by Michael CroftBLUEBELL, PA - Sep 28, 2016 - A global life science technology firm has appointed James OBrien to lead its manufacturing execution system (MES) business to its next phase of growthFull story -
Unmet Medical Needs of Population in Emerging Economies will Support Acute Care Management
Sep 28, 2016, 04:42 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 28, 2016 - Acute care is a branch of secondary health care in which short term treatment is provided to patients for their various medical conditions such as severe injury and recovery from surgeryFull story -
Creative Biolabs Released Anti-idiotypic Antibody Production Service for Antibody Drug Development
Sep 27, 2016, 22:21 PM by Michael CroftSHIRLEY, NY, USA - Sep 28, 2016 - With years of experience in antibody research and development, Creative Biolabs released anti-idiotypic antibody production service to further support researchers in the field of antibody related studiesFull story -
PRP a Biologic Treatment Helping Innovate Pain Relief Techniques!
Sep 27, 2016, 15:28 PM by Michael CroftFULLERTON,, CA, UNITED STATES - Sep 28, 2016 - PRP is a Biologic Treatment. PRP is a Pain Management Alternative method of nonsurgical management of soft-tissue and musculoskeletal conditionsFull story -
Color Genomics Raises $45 Million To Expand Genetic Testing
Sep 27, 2016, 11:31 AM by Michael CroftBloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.Full story -
Kite Unveils Anticipated CAR-T Cancer Data Positive But Not Complete
Sep 27, 2016, 10:52 AM by Michael CroftXconomy | Kite Pharma has dipped into a highly anticipated clinical trial of its cancer treatment, KTE-C19, to release a partial set of data. Although not complete, the data bolster the view that Kite could be the first among its peers to win the FDA's green light.Full story


